Supplementary Figure S1 from Negative Hyperselection of Patients with HER2⁺ and <i>RAS</i> Wild-Type Metastatic Colorectal Cancer Receiving Dual HER2 Blockade: the PRESSING-HER2 Study

Randon G., Nakamura Y., Yaeger R., Lonardi S., Cremolini C., Elez E., Nichetti F., Ghelardi F., Nasca V., Bergamo F., Conca V., Ros J., Bando H., Maddalena G., Oldani S., Prisciandaro M., Raimondi A., Schrock AB., Agnelli L., Walch H., Yoshino T., Pietrantonio F.